Pacific Biosciences Of California, Inc. SEC filings PACB
Pacific Biosciences Of California, Inc. has 972 filings in SEC EDGAR's recent list, going back to Jul 28, 2004. Its latest annual report, Form ARS, was filed on Apr 23, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (results of operations, officer or director change). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEFA14A | Additional proxy material | May 22, 2026 | — |
| DEFA14A | Additional proxy material | Apr 23, 2026 | — |
| DEF 14A | Proxy statement | Apr 23, 2026 | Jun 3, 2026 |
| DEFA14A | Additional proxy material | May 20, 2025 | — |
| DEFA14A | Additional proxy material | Apr 23, 2025 | — |
| DEF 14A | Proxy statement | Apr 23, 2025 | Jun 4, 2025 |
| DEFA14A | Additional proxy material | May 30, 2024 | — |
| DEFA14A | Additional proxy material | Apr 29, 2024 | — |
| DEF 14A | Proxy statement | Apr 29, 2024 | Jun 18, 2024 |
| PRE 14A | Preliminary proxy statement | Apr 15, 2024 | Jun 18, 2024 |
| DEFA14A | Additional proxy material | Apr 13, 2023 | — |
| DEF 14A | Proxy statement | Apr 13, 2023 | — |
| PRE 14A | Preliminary proxy statement | Mar 27, 2023 | — |
| DEFA14A | Additional proxy material | May 24, 2022 | — |
| DEFA14A | Additional proxy material | May 9, 2022 | — |
| DEFA14A | Additional proxy material | May 6, 2022 | — |
| DEFA14A | Additional proxy material | Apr 14, 2022 | — |
| DEF 14A | Proxy statement | Apr 14, 2022 | May 25, 2022 |
| DEFA14A | Additional proxy material | Apr 30, 2021 | — |
| DEF 14A | Proxy statement | Apr 30, 2021 | Jun 16, 2021 |
| DEFA14A | Additional proxy material | Apr 29, 2021 | — |
| DEFA14A | Additional proxy material | Apr 27, 2021 | — |
| DEFA14A | Additional proxy material | Jun 24, 2020 | — |
| DEFA14A | Additional proxy material | Jun 24, 2020 | — |
| DEFA14A | Additional proxy material | Jun 8, 2020 | — |
| DEFA14A | Additional proxy material | Apr 28, 2020 | — |
| DEF 14A | Proxy statement | Apr 28, 2020 | Apr 28, 2020 |
| DEF 14A | Proxy statement | Apr 29, 2019 | Apr 29, 2019 |
| DEFM14A | Definitive proxy statement pertaining to a merger | Dec 18, 2018 | — |
| PREM14A | Preliminary proxy statement pertaining to a merger | Dec 5, 2018 | Dec 4, 2018 |
| DEFA14A | Additional proxy material | Nov 5, 2018 | — |
| DEF 14A | Proxy statement | Apr 4, 2018 | Apr 4, 2018 |
| DEF 14A | Proxy statement | Apr 4, 2017 | Apr 4, 2017 |
| DEF 14A | Proxy statement | Apr 4, 2016 | Apr 4, 2016 |
| DEF 14A | Proxy statement | Apr 6, 2015 | Apr 3, 2015 |
| DEF 14A | Proxy statement | Apr 16, 2014 | Apr 16, 2014 |
| DEF 14A | Proxy statement | Apr 16, 2013 | May 21, 2013 |
| DEF 14A | Proxy statement | Apr 27, 2012 | Jun 13, 2012 |
| DEF 14A | Proxy statement | Apr 29, 2011 | Jun 23, 2011 |
Showing 39 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Laboratory Analytical Instruments (SIC 3826)
- Listed as
- PACB (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Menlo Park, CA
- SEC filer status
- Accelerated filer
- SEC CIK
- 1299130
- Former names
- PACIFIC BIOSCIENCES OF CALIFORNIA INC (until Feb 5, 2013); NANOFLUIDICS INC (until Jul 28, 2004)
Other Laboratory Analytical Instruments companies
- Agilent Technologies, Inc. A
- Waters Corp /DE/ WAT
- Illumina, Inc. ILMN
- Mettler Toledo International INC/ MTD
- Revvity, Inc. RVTY
- Avantor, Inc. AVTR
- Bio-Rad Laboratories, Inc. BIO
- Bruker Corp BRKR
Source: SEC EDGAR filings. This is company-reported data, not investment advice.